Oncolytics Biotech Inc ONCY

oh dear

[Quentin30]

Like I said 6 months ago, the triplet therapy needed to show huge improvement over the doublet... and so here we are with results... triplet with CPI did nothing. All the noteable dreamers were too busy getting dizzy with multi-billion dollar valuations to ask the question, what IF Pela+Pax+CPI does not work...

trading today will tell us what exactly what the market thinks about this 'grounbreaking data..."

The PFS difference shown is great, let's now hope that evidences as even better OS data for the doublet. But they need to get this Phase III underway..

They should be ready to go, because they ought to have been planning for either scenario. 

hope you all like waiting.. as I still don't see the phase III getting underway in 2023.

[Noteable]

According to Dr. Vile the issues with checkpoint inhibitors have to do with the timing of the administration, as I have always suggested, and specific to the checkpoint inhibitor avelumab, Dr. Vile believes that Bavencio is cleared too quickly from the cell due to the Fc component, and therefore did not have the desired affect that other immune checkpoint inhibitors could offer. Consequently

[Quentin30]

Maybe not Noteable.. but they will run out of time to get such a combination into Phase III before the patent expires.. if this news were being well recieved, we would see an appreciation of pps... it's been seen as yet another nothing burger.. So, still no partner, which means NO phase III, no mention of biomarkers, no accelerated approval... just more... wait and see, and we hope to get

[Azzak34]

What a tool you are. Sell your "considerable" position, you clearly don't know what you're talking about. 

[Quentin30]

Azzak34 - KOL presentation... and compelling new data...  yet ONCY pps is down again.  Please explain what I am missing...? What is it the market seems to dislike about this company ? Is it perhaps 24 years of missed timelines, non statisically powered data, unclear signals of efficacy, prior failed Phase III trial, ? Clinical Trial partners who have exclusive access to the data

[Azzak34]

The results are brilliant you fool. 69%Orr in panc and 150% pfs efficacy for paclitaxel?  Pps is based on you idiots shorting and shenanigans. Go nuts, I'll not be selling 1 share. Results are great, team is amazing. You'll not be able to piss about much longer so enjoy it now.